Search Results - "Shiho Kuji"

Refine Results
  1. 1

    A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases by Kuji, Shiho, Watanabe, Reiko, Sato, Yuichi, Iwata, Takashi, Hirashima, Yasuyuki, Takekuma, Munetaka, Ito, Ichiro, Abe, Masato, Nagashio, Ryo, Omae, Katsuhiro, Aoki, Daisuke, Kameya, Toru

    Published in Gynecologic oncology (01-02-2017)
    “…Abstract Objective High-grade neuroendocrine carcinoma of uterine cervix (HGNCUC) has been recognized as a highly malignant tumor. Therapeutic strategy…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Current state of fertility preservation for adolescent and young adult patients with gynecological cancer by Ohara, Tatsuru, Kuji, Shiho, Takenaga, Tomo, Imai, Haruka, Endo, Hiraku, Kanamori, Ryo, Takeuchi, Jun, Nagasawa, Yuko, Yokomichi, Noriyuki, Kondo, Haruhiro, Deura, Imari, Tozawa, Akiko, Suzuki, Nao

    “…Although the incidence of the various gynecological cancers has been increasing in recent years, long-term survival is now possible for many patients thanks to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix by Kuji, Shiho, Endo, Akira, Kubota, Manabu, Uekawa, Atsushi, Kawakami, Fumi, Mikami, Yoshiki, Koike, Junki, Suzuki, Nao

    Published in Journal of gynecologic oncology (01-01-2023)
    “…Previously, we reported that insulinoma-associated protein 1 (INSM1) immunohistochemistry (IHC) showed high sensitivity for neuroendocrine carcinoma of the…”
    Get full text
    Journal Article
  6. 6

    The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I–II cervical cancer: A review by Takekuma, Munetaka, Kasamatsu, Yuka, Kado, Nobuhiro, Kuji, Shiho, Tanaka, Aki, Takahashi, Nobutaka, Abe, Masakazu, Hirashima, Yasuyuki

    “…The treatment for most patients with early‐stage cervical cancer involves radical hysterectomy and pelvic lymph node dissection, and indications for…”
    Get full text
    Journal Article
  7. 7

    Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy by Takekuma, Munetaka, Kasamatsu, Yuka, Kado, Nobuhiro, Kuji, Shiho, Tanaka, Aki, Takahashi, Nobutaka, Abe, Masakazu, Hirashima, Yasuyuki

    Published in International journal of clinical oncology (01-08-2016)
    “…Background The aims of this study were to evaluate the efficacy and toxicity of chemotherapy (CT) compared with concurrent chemoradiotherapy (CCRT) after…”
    Get full text
    Journal Article
  8. 8

    A simple technique of vaginal cuff closure to prevent tumor cell spillage in laparoscopic radical hysterectomy for uterine cervical cancer by Deura, Imari, Kanamori, Ryo, Nagasawa, Yuko, Kuji, Shiho, Ohara, Tatsuru, Tozawa, Akiko, Shimada, Muneaki, Suzuki, Nao

    Published in Asian journal of endoscopic surgery (01-07-2021)
    “…Introduction The Laparoscopic Approach to Cervical Cancer (LACC) trial, a prospective randomized phase III clinical trial reported in 2018, unexpectedly showed…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix by Shiho Kuji, Akira Endo, Manabu Kubota, Atsushi Uekawa, Fumi Kawakami, Yoshiki Mikami, Junki Koike, Nao Suzuki

    Published in Journal of gynecologic oncology (01-01-2023)
    “…Objective: Previously, we reported that insulinoma-associated protein 1 (INSM1) immunohistochemistry (IHC) showed high sensitivity for neuroendocrine carcinoma…”
    Get full text
    Journal Article
  11. 11

    Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy by Hirashima, Yasuyuki, Takahashi, Nobutaka, Tanaka, Aki, Kuji, Shiho, Kado, Nobuhiro, Kasamatsu, Yuka, Abe, Masakazu, Takekuma, Munetaka

    Published in BioMed research international (01-01-2015)
    “…Objective. Olanzapine is proved to be effective for chemotherapy induced nausea and vomiting (CINV). But its efficacy in combination with standard antiemetic…”
    Get full text
    Journal Article
  12. 12

    Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer by Takekuma, Munetaka, Kuji, Shiho, Tanaka, Aki, Takahashi, Nobutaka, Abe, Masakazu, Hirashima, Yasuyuki

    Published in Journal of gynecologic oncology (01-07-2015)
    “…The concept of platinum sensitivity and cross-resistance among platinum agents are widely known in the management of recurrent ovarian cancer. The aim of this…”
    Get full text
    Journal Article
  13. 13

    Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer by Takekuma, Munetaka, Kasamatsu, Yuka, Kado, Nobuhiro, Kuji, Shiho, Tanaka, Aki, Takahashi, Nobutaka, Abe, Masakazu, Hirashima, Yasuyuki

    “…Aim The aim of this retrospective study was to analyze data for patients with stage IB–IIB uterine cervical cancer who were treated with concurrent…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer by Kuji, Shiho, Hirashima, Yasuyuki, Komeda, Satomi, Tanaka, Aki, Abe, Masakazu, Takahashi, Nobutaka, Takekuma, Munetaka

    Published in Journal of gynecologic oncology (01-04-2014)
    “…The purpose of this study was to assess whether peritoneal cytology has prognostic significance in uterine cervical cancer. Peritoneal cytology was obtained in…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer by Munetaka Takekuma, Shiho Kuji, Aki Tanaka, Nobutaka Takahashi, Masakazu Abe, Yasuyuki Hirashima

    Published in Journal of gynecologic oncology (31-07-2015)
    “…Objective: The concept of platinum sensitivity and cross-resistance among platinum agents are widely known in the management of recurrent ovarian cancer. The…”
    Get full text
    Journal Article
  19. 19

    The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer by Shiho Kuji, Yasuyuki Hirashima, Satomi Komeda, Aki Tanaka, Masakazu Abe, Nobutaka Takahashi, Munetaka Takekuma

    Published in Journal of gynecologic oncology (30-04-2014)
    “…Objective: The purpose of this study was to assess whether peritoneal cytology has prognostic significance in uterine cervical cancer. Methods: Peritoneal…”
    Get full text
    Journal Article
  20. 20